annb0t
Top 20
Immutep Limited
Late-breaking abstract one of nineabstracts selected by
SITC Communications Committee to be showcased at the SITC 2022 Press Conference
Company to host Webcast on Thursday, 10th November at 5PM ET
to discuss datain Late-Breaking Oral Abstract Presentation
SYDNEY, AUSTRALIA, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for ...
>>> Read more: Immutep Announces Abstract Highlighting Eftilagimod Alpha Selected for SITC 2022 Annual Meeting Press Conference
Late-breaking abstract one of nineabstracts selected by
SITC Communications Committee to be showcased at the SITC 2022 Press Conference
Company to host Webcast on Thursday, 10th November at 5PM ET
to discuss datain Late-Breaking Oral Abstract Presentation
SYDNEY, AUSTRALIA, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for ...
>>> Read more: Immutep Announces Abstract Highlighting Eftilagimod Alpha Selected for SITC 2022 Annual Meeting Press Conference